Two Seas Capital LP Roivant Sciences Ltd. Transaction History
Two Seas Capital LP
- $297 Million
- Q3 2024
A detailed history of Two Seas Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Two Seas Capital LP holds 9,724,893 shares of ROIV stock, worth $113 Million. This represents 37.75% of its overall portfolio holdings.
Number of Shares
9,724,893
Previous 10,318,764
5.76%
Holding current value
$113 Million
Previous $109 Million
2.89%
% of portfolio
37.75%
Previous 43.6%
Shares
12 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$763 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$761 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$626 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$482 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...